Delivery Order SPE2DB20D2014-SPE2DB25FC57H
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QUVIVIQ 25 MG TABLET 30S. The contract has a firm fixed price of $1,027.28 and a performance period through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation. The order is for 4561969808 Quviviq 25 mg tablets to be delivered within a one-day period ending August 29, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply procurement programs. As...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,528.80, is for the delivery of QUVIVIQ 50 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp is a large, for-profit pharmaceutical distribution company that plays a critical role in supplying medical...
- This is a $1,264.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- The Defense Logistics Agency Troop Support Medical awarded a $123,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561941797 Quviviq 25 mg tablets. The order is for 30 boxes of the medication to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. Amerisourcebergen will serve as the prime contractor on the order, with no subcontractors...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-three thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for the supply of fifty milligram Quviviq tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver thirty tablets of the specified medication to a facility in Conshohocken, Pennsylvania between August 11th and 14th, 2023. The Defense Logistics Agency routinely utilizes...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately one thousand dollars to Amerisourcebergen Drug Corporation for 25mg Quviviq tablets. Under this order, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between September 20th and 21st of 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this award...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,481.60 and is for the delivery of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.74 Firm Fixed Price Delivery Order is for the supply of the prescription medication QUVIVIQ 25 MG TABLET 30S, with a completion date of June 21, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC57HDelivery Order
The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999.999 billion IDC with DLA Troop Support Medical (contract SPE2DX) through December 2026, which serves as the overarching vehicle for this delivery order. As a critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/28/25 |